Containing Or Obtained From Linaceae (e.g., Flaxseed, Linseed, Etc.) Patents (Class 424/768)
  • Patent number: 11116810
    Abstract: Methods for the treatment of irritations of the skin and skin appendages caused by microbial stresses are disclosed. The methods include providing a composition comprising a linseed extract, obtained from hydrolysis of linseed proteins, as an active antimicrobial agent in a physiologically acceptable medium, and topically applying the linseed extract onto the skin in need thereof. The methods may be useful in the cosmetic and pharmaceutical field and, more particularly, in the field of dermatology. Cosmetic methods for reinforcing the chemical barrier function of healthy and/or sensitive skin and skin appendages are also disclosed that include the same or similar composition and steps.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: September 14, 2021
    Assignee: ISP INVESTMENTS LLC
    Inventors: Jean-Marie Botto, Nouha Domloge, Frederique Portolan
  • Patent number: 10966995
    Abstract: The invention provides compositions and methods for radioprotection and chemoprevention using therapeutic and prophylactics methods of using (S,S)-SDG (R,R)-SDG, (S,R)-SDG (R,S)-SDG, SDG, SECO, EL, ED, analogs thereof, stereoisomers thereof and other related molecules.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: April 6, 2021
    Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventor: Melpo Christofidou-Solomidou
  • Patent number: 8986757
    Abstract: Methods of treating wood lumber to inhibit growth of mold fungi by surface treating the wood lumber with an essential oil, diluted or undiluted, being geranium Egyptian, thyme, dill weed or rosemary. Various surface treatments include dipping, spraying, brushing and vapor exposure.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: March 24, 2015
    Assignee: The United States of America as Represented by the Secretary of Agriculture
    Inventors: Vina W. Yang, Carol A. Clausen
  • Patent number: 8877267
    Abstract: The present invention relates to methods for reducing fat uptake in the gastrointestinal tract of a mammal in order to prevent a positive energy balance, weight gain, overweight and obesity, and to induce a negative energy balance and weight loss in subjects who wish to reduce their body weight. In particular, food and/or beverage ingredients and dietary supplements of the present invention comprises flaxseeds useful for increasing faeca fat excretion from the gastrointestinal tract.
    Type: Grant
    Filed: May 10, 2005
    Date of Patent: November 4, 2014
    Assignee: University of Copenhagen
    Inventors: Arne Vernon Astrup, Inge Tetens, Agnete Dal Thomsen
  • Publication number: 20140308379
    Abstract: The invention provides compositions and methods for treating neurological disorders and viral infection using whole-grain flaxseed, flaxseed lignans such as Secoisolariciresinol diglucoside (SDG), human lignans metabolized from flaxseed such as Enterodiol (ED) or Enterolactone (EL), and synthetic flaxseed lignan analogs.
    Type: Application
    Filed: November 19, 2013
    Publication date: October 16, 2014
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: Melpo CHRISTOFIDOU-SOLOMIDOU, Kelly JORDAN-SCIUTTO
  • Patent number: 8846118
    Abstract: The present invention relates to compositions for the protection, treatment and repair of connective tissues in humans and animals comprising any or all of anabolic, anti-catabolic, anti-oxidant and analgesic agents, including aminosugars, S-adenosylmethionine, arachadonic acid, GAGs, including pentosan, collagen type II, tetracyclines or tetracycline-like compounds, diacerin, super oxide dismutase, L-ergothionine, one or more avocado/soybean unsaponifiables, and an analgesic, e.g., acetaminophen, and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.
    Type: Grant
    Filed: August 21, 2008
    Date of Patent: September 30, 2014
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd R. Henderson, Tarek Hammad, Medhat Soliman, Barbara E. Corson, Louis Lippiello, Robert W. Henderson
  • Publication number: 20140248381
    Abstract: The present invention discloses a composition for inhibiting vascular aging comprising a compound of Chemical formula 1, a derivative thereof or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: October 25, 2012
    Publication date: September 4, 2014
    Inventors: Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20140242055
    Abstract: Provided herein are compositions and methods for preparing foods and beverages that contain additives, such as nutraceuticals, pharmaceuticals, and supplements, such as essential fatty acids, including omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, and other fatty acids; phytochemicals, including phytosterols; other oils; and coenzymes, including Coenzyme Q10, and other oil-based additives.
    Type: Application
    Filed: May 7, 2014
    Publication date: August 28, 2014
    Inventor: Philip J. Bromley
  • Patent number: 8728546
    Abstract: The invention provides a medicament for the treatment of cancer, cardiovascular diseases and/or inflammation. The medicament may be administered orally, parenterally or topically.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: May 20, 2014
    Assignee: Swing Aerobics Licensing, Inc.
    Inventor: Brian Peskin
  • Patent number: 8691293
    Abstract: A low inflammatory oil composition and method for supplementing feed, nutrition and diet systems with omega-3 to omega-6 balanced oils comprised of a synergistic blend of at least two oils. The composition further comprises a synergistic blend of long chain omega-3 oil as a means to further increase the nutritional value. The composition further provides an effective increase in reducing inflammation for therapeutic, and pharmacological treatment in addition to general nutrition and diet systems.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: April 8, 2014
    Assignee: Omega Foods, LLC
    Inventor: Michael H Gurin
  • Patent number: 8679555
    Abstract: The present invention relates to a method for producing organically-bound vitamin B, preferably vitamin B1, B2, B3, B5, B6, B7, B9, B12, or mixtures thereof, in plants, wherein plant seeds are soaked in the solution of the respective vitamin and are cultured to vitamin-B-enriched germ buds by subsequent sprinkling.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: March 25, 2014
    Assignee: JHS-Privatstiftung
    Inventors: Norbert Fuchs, Rupert Loidl, Behzad Sadeghi
  • Publication number: 20130337094
    Abstract: The present invention provides a novel composition of nut and seed oils, specifically; walnut oil, almond oil, avocado oil, pistachio oil and flaxseed oil for use in maintaining and improving health in a convenient and cost-effective manner; for obtaining essential fatty acids that are required for normal body functioning; for reducing cholesterol, and for reducing retinal degeneration in an individual with retinitis pigmentosa.
    Type: Application
    Filed: August 26, 2013
    Publication date: December 19, 2013
    Applicant: Dr. Baker Says, Inc.
    Inventor: Andrew Baker
  • Patent number: 8512772
    Abstract: A dietary supplement which is useful for human hair pigment augmentation is provided. The dietary supplement contains black beans, black seeds, walnuts and flaxseeds, which are arranged in substantially equal amounts. This human hair pigment augmentation is achieved naturally without the use of dyes, colorants, or the like.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: August 20, 2013
    Inventor: Asma Mirza
  • Patent number: 8491940
    Abstract: A substantially non-aqueous, aerated composition is free of petroleum-based components and is suitable for skin applications. The composition primarily includes wax and oil, and can further include vitamin E oil and an essential oil. The composition can be a semi-solid at room temperature. A method of making the composition includes melting together component ingredients to form a mixture, which is then cooled to form hardened matter. The hardened matter is blended to form a flowable mixture, which is then forced through a sieve to form the aerated composition.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: July 23, 2013
    Assignee: Waxelene, Inc.
    Inventors: Chris Ejyo Remington, Todd Stuart Cooper
  • Patent number: 8431165
    Abstract: A medicament for the treatment of cancer and other diseases, including cardiovascular diseases, by increasing cellular oxygenation is described wherein a composition of organically grown, chemically unprocessed and unrefined oils is used that provides a ratio of parent omega-6 to parent omega-3 that is greater than 1:1 and preferably within a range from about 1.1:1 to about 5:1. Most preferably, the ratio is about 2.6:1. The medicament may be administered via capsule or liquid form and preferably on a periodic basis, such as daily. In further embodiments, the medicament may be applied in topical ointment form.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: April 30, 2013
    Assignee: Swing Aerobics Licensing, Inc.
    Inventor: Brian Peskin
  • Patent number: 8409550
    Abstract: A skin care product comprising from about 0.001% to about 10% of a retinoid, in combination with 0.0001% to about 50% of at combination of retinoid boosters.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: April 2, 2013
    Assignee: Unilever Home & Personal Care, USA, Division of Conopco, Inc.
    Inventors: Stewart Paton Granger, Ian Richard Scott, Robert Mark Donovan, Susanne Teklits Iobst, Lisa Licameli
  • Patent number: 8394429
    Abstract: A herbal composition comprising supercritical fluid extracts/oils of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E is effective in the treatment of symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD).
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: March 12, 2013
    Assignee: Nisarga Biotech Pvt. Ltd.
    Inventors: Girish Sudhakar Soman, Shrikrishna Govind Phadke
  • Patent number: 8383172
    Abstract: Methods for separation and recovery of individual cyclic peptides from plant materials, said method comprising the steps of: (a) extracting an oil from a plant material; (b) separating the extracted oil into a non-polar fraction and a polar fraction; (c) separation and recovery of cyclic peptides from the non-polar fraction, and (d) separation and recovery of cyclic peptides from the polar fraction. The methods are suitable for separation and recovery of individual cyclolinopeptides from flax seed oil. Individual cyclolinopeptides are useful for modulation physiological disorders associated with apoptosis. Modified flaxseed oils may be produced by commingling flaxseed oils absent cyclolinopeptides, with at least one cyclolinopeptide separated and recovered with the methods disclosed herein.
    Type: Grant
    Filed: December 22, 2008
    Date of Patent: February 26, 2013
    Assignee: University of Saskatchewan
    Inventors: Martin J. Reaney, Yunhua Jia, Jianheng Shen, Cynthia Schock, Nancy Tyler, Jim Elder, Sarabjeet Singh
  • Publication number: 20130045183
    Abstract: The present disclosure relates to non-acidic extracts or fractions selected from a Boswellia low polar gum resin extract fraction (BLPRE), a Boswellia volatile oil fraction (BVOIL), and a Boswellia oil fraction (BOIL) and their compositions. BLPRE, BOIL, and BVOIL are each derived from the gum resin of a Boswellia species. These compositions are useful for improving mental condition, enhancing brain functions such as cognition, memory, learning, communication and brain health, for treating impaired memory, and for preventing, control or treating memory and cognition related disorders/diseases. Additionally, BOIL, BVOIL, and mixtures of BOIL and BVOIL are useful for enhancing the bioavailability of a biological agent.
    Type: Application
    Filed: September 14, 2012
    Publication date: February 21, 2013
    Applicant: LAILA NUTRACEUTICALS
    Inventors: Ganga Raju GOKARAJU, Rama Raju GOKARAJU, Venkata Kanaka Ranga Raju GOKARAJU, Trimurtulu GOLAKOTI, Kiran BHUPATHIRAJU, Venkata Krishna Raju ALLURI
  • Patent number: 8377465
    Abstract: The present invention provides feed or food products for consumption by animals or humans which include respective quantities of flax oil and non-flax carbohydrate. The flax oil and carbohydrate are mixed together and simultaneously subjected to an elevated temperature of at least about 120° F. and subsequently cooled; the flax oil is used at a level so that the final product contains at least about 5% by weight flax oil. It has been found that the products of the invention, when fed at effective levels, induce increased in vivo synthesis of desirable eicosapentaenoic acid (EPA).
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: February 19, 2013
    Assignee: Kansas State University Research Foundation
    Inventor: James S. Drouillard
  • Publication number: 20130034620
    Abstract: Disclosed are an antibacterial synthetic fiber, and a method for manufacturing the same, characterized in that one or more antibacterial plant extracts are mixed with a fiber-formable polymer and the mixture is melt spun at 200˜300° C. The antibacterial synthetic fiber exhibits excellent and persistent antibacterial activity. In addition, the antibacterial synthetic fiber is superior in physical property to conventional antibacterial fibers and is suitable for use as a material for clothes.
    Type: Application
    Filed: February 1, 2012
    Publication date: February 7, 2013
    Inventors: In-Sik Yoo, Myung-Ho Seok
  • Publication number: 20120263694
    Abstract: The kit comprises applicators of lubricating composition for use during the days up to and including ovulation and applicators of a slightly thicker composition for use just after ovulation. The lubricating composition is neutral or slightly acid with a view to being sperm friendly. The thicker composition is slightly acid to mirror vaginal acidity and includes a moisturiser for vaginal friendliness. It is also a lubricant.
    Type: Application
    Filed: December 13, 2011
    Publication date: October 18, 2012
    Inventors: Susan Mary Lennox, Sarah Annabelle Brooks
  • Publication number: 20120258061
    Abstract: A skin care product comprising from about 0.001% to about 10% of a retinoid in combination with 0.0001% to about 50% of at combination of retinoid hoosters.
    Type: Application
    Filed: June 21, 2012
    Publication date: October 11, 2012
    Applicant: CONOPCO, INC., D/B/A UNILEVER
    Inventors: Stewart Paton Granger, Ian Richard Scott, Robert Mark Donovan, Susanne Teklits Iobst, Lisa Licameli
  • Publication number: 20120189723
    Abstract: A herbal composition comprising supercritical fluid extracts/oils of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E is effective in the treatment of symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD).
    Type: Application
    Filed: December 29, 2011
    Publication date: July 26, 2012
    Applicant: NISARGA BIOTECH PVT.LTD.
    Inventors: Girish Sudhakar SOMAN, Shrikrishna Govind Phadke
  • Patent number: 8178106
    Abstract: Disclosed is a topical skin care composition comprising: (a) a combination of the following extracts: Malpighia punicifolia (acerola) extract; Argania spinosa (argan) extract; Myrciaria dubia (camu camu) extract; Punica granatum (pomegrannate) extract; Pinus sylvestris extract; Terminalia ferdinandiana (kakadu plum) extract; Linum usitatissimum (linseed) extract; Ribes nigrum (black current) extract; Secale cereale (rye) extract; algae extract; and yeast extract; and (b) a dermatologically acceptable vehicle.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: May 15, 2012
    Assignee: Mary Kay Inc.
    Inventors: Michelle Hines, Tiffany Florence
  • Publication number: 20120100223
    Abstract: Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the aforementioned for the prophylaxis and treatment of numerous diseases are disclosed. The compositions include omega-6 and omega-3 fatty acids where the ratio of the omega-6 to the omega-3 fatty acids and their amounts are controlled based on one or more factors including age of the subject, sex of the subject, diet of the subject, the body weight of the subject, medical conditions of the subject, and climate of the subject's living area.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 26, 2012
    Applicant: ASHA NUTRITION SCIENCES, INC.
    Inventor: Urvashi BHAGAT
  • Publication number: 20120093906
    Abstract: Emulsions, emulsifier, a method of use and a production process of said emulsions are presented in the present invention. The emulsion composed of a mixture of water and oils and additives sheared into small droplets using a low pressure, three shearing stage emulsifier. The oils used in the preparation of said emulsions are botanical oils and in most cases, edible oils.
    Type: Application
    Filed: April 18, 2010
    Publication date: April 19, 2012
    Inventors: Shmuel Ganmor, Beni Ronen
  • Publication number: 20120087987
    Abstract: The present disclosure relates to the combined use of two pesticides. A first pesticide composition provides an initial contact kill, and may form a barrier when applied to greasy surfaces. A second pesticide composition provides residual pesticidal activity on the surface. Methods of making and using the pesticide compositions are also provided.
    Type: Application
    Filed: October 12, 2011
    Publication date: April 12, 2012
    Applicant: ECOLAB USA INC.
    Inventors: Victor F. Man, S. John Barcay, Darren M. Jahnke, Yvonne M. Killeen
  • Patent number: 8124142
    Abstract: The present invention includes a cranberry seed oil, a cranberry flour and a method for making cranberry seed oil and flour. The cranberry seed oil comprises beta sitosterol and phosphatidylcholine.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: February 28, 2012
    Inventors: Tim Heeg, Bernard G. Lager, II
  • Patent number: 8110229
    Abstract: Disclosed herein is a herbal composition comprising supercritical fluid extracts/oils of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E in an effective amounts useful in the treatment of symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD).
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: February 7, 2012
    Assignee: Nisarga Biotech Pvt Ltd.
    Inventors: Girish Sudhakar Soman, Shrikrishna Govind Phadke
  • Patent number: 8092839
    Abstract: A medicament for treatment of cancer or other diseases by increasing cellular oxygenation is described wherein a composition of oils is used that provides a ratio of parent omega 6 to parent omega 3 that is greater than 1:1 and preferably within a range from about 1.1:1 to about 5:1. Most preferably, the ratio is about 2.6:1. The medicament may be administered via capsule or liquid form and preferably on a periodic basis, such as daily. In further embodiments, the medicament may be applied in topical ointment form.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: January 10, 2012
    Assignee: Swing Aerobics Licensing, Inc.
    Inventor: Brian Peskin
  • Patent number: 8080266
    Abstract: Described herein are compositions comprising a nematicide intermixed with lecithin and a co-surfactant that form stable dispersions in water. Also disclosed are methods of controlling nematodes in soil by application of such compositions.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: December 20, 2011
    Assignee: Archer Daniels Midland Company
    Inventor: Shireen Baseeth
  • Publication number: 20110300247
    Abstract: The invention relates compositions and methods for treating pathological lung conditions using whole-grain flaxseed or flaxseed lignans. Specifically, the invention relates to the dietary use of flaxseed lignans.
    Type: Application
    Filed: April 11, 2011
    Publication date: December 8, 2011
    Inventor: Melpo CHRISTOFIDOU-SOLOMIDOU
  • Patent number: 8062688
    Abstract: Nutritional food oil compositions containing all of the essential fatty acids and the highly recommended omega-3 fatty acid DHA in correct proportions making it convenient and easy for consumers to supplement their diets with these fatty acids in the proper amounts, thereby deriving the health benefits of these fatty acids. A nutritional food oil composition is provided comprising alpha-linolenic acid (ALA) and linoleic acid (LA), wherein the ratio of the amount of ALA to LA in the composition by weight is in the range of 1.5:1 to 6:1, and together the ALA and LA comprise at least 65% by weight of the composition, and docahexaenoic acid (DHA) from an algal source in an amount greater than 0.5% by weight of the composition.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: November 22, 2011
    Inventor: Thomas Greither
  • Publication number: 20110274772
    Abstract: The present invention provides an ointment comprising aqueous extract of fig leaves, horse chestnut, artichoke leaves and walnut shells, for the treatment of haemorrhoids; a method of manufacturing such an ointment; and the use of fig leaves, artichoke leaves or walnut shells for the manufacture of a medicament for the treatment of haemorrhoids. Preferably, the ointment further comprises lanolin and petroleum gelly (Vaseline). Preferably, the method comprises extracting fig leaves, horse chestnut, artichoke leaves and/or walnut shells using heated water, and admixing thereto lanolin and petroleum gelly (Vaseline) so as to result in the ointment. The ointment preferably further comprises ‘Huile de Cade’.
    Type: Application
    Filed: January 13, 2009
    Publication date: November 10, 2011
    Inventors: Feyyaz Kucukay, Mehmet Sait Kucukay
  • Publication number: 20110268811
    Abstract: A composition and method which improves blood lipid profiles and optionally reduces low density lipoprotein (LDL) per-oxidation in humans by administering a therapeutic amount of a composition comprising krill oil in combination with astaxanthin or a mixture of fish oil derived, choline based, phospholipid bound omega-3 fatty acid mixture including phospholipid bound polyunsaturated EPA and DHA. In one embodiment, the krill oil is derived from Euphasia spp., comprising Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) fatty acids in the form of triacylglycerides and phospholipids. The krill oil includes at least 10% EPA and 5% DHA, of which greater than 50% are in the form of phospholipids and the 1-4000 mg of krill oil per daily dose is delivered.
    Type: Application
    Filed: April 25, 2011
    Publication date: November 3, 2011
    Applicant: U.S. Nutraceuticals, LLC d/b/a Valensa International
    Inventors: John A. MINATELLI, W. Stephen Hill, Rudi E. Moerck
  • Publication number: 20110250270
    Abstract: A composition that has a capillary-active system C optionally containing a capillary activator system CA consisting of drugs that increase blood flow, stabilize the vascular wall, and/or dilate the blood vessels; and/or a capillary-protective system CP comprising drugs for endothelial stabilization, lipoprotein protection, and for stabilization of leukocytes/platelets; and/or a capillary energy supply system CE comprising redox systems and cofactors in energy provision and energy carriers. This system C is combined with a selective action system S. The compositions are useful, systemically or enterally, especially for the selective control, for example, of structural changes, functional disturbances of the target organs in question (hair, skin, cerebrum, skeleton, muscles, gastrointestinal tract, eyes) as supplements (food supplements, supplementary balanced diet, dietary components), or pharmaceutical agents.
    Type: Application
    Filed: June 16, 2011
    Publication date: October 13, 2011
    Applicant: Merz Pharma GmbH & Co. KGaA
    Inventors: Rolf D. Beutler, Karl-Heinz Schmidt, Bettina Funke, Kirstin Becker
  • Publication number: 20110223193
    Abstract: Method of selecting and preparing medical devices comprising extracts of plants and natural substances devoid of pharmacologically, immunologically or metabolically active fractions and characterised by a content of substances able to exert beneficial effects on the body, mediated by mechanical or physical effects, which said process comprises: a) removal by conventional processes of any pharmacologically, immunologically or metabolically active fractions from extracts of plants or natural substances; b) biological testing to establish that the extract or substance obtained in a) is devoid of pharmacological, metabolic and immunological effects; c) formulation of the extracts or substances that pass the test conducted at stage b) into suitable medical devices.
    Type: Application
    Filed: November 10, 2009
    Publication date: September 15, 2011
    Applicant: ABOCA S.P.A. SOCIETA ARGRICOLA
    Inventor: Valentino Mercati
  • Patent number: 7998507
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Grant
    Filed: December 7, 2005
    Date of Patent: August 16, 2011
    Assignee: Elan Pharma International Ltd.
    Inventors: H. William Bosch, Greta G. Cary, Douglas C. Hovey, Rajeev A. Jain, Laura J. Kline, Elaine Merisko-Liversidge, Kevin D. Ostrander, Niels P. Ryde, Stephen B. Ruddy
  • Publication number: 20110189319
    Abstract: Two very important factors in human life—which play vital roles in promoting well being—includes returning the body to homeostasis and giving boost to body called lifeforce to get overall health free from diseases, i.e., its optimal balanced functioning ability. When the body is at homeostasis, there is no place for disease. It is only when the body is out of balance (something is deficient, in excess or stagnating) that pain, illness or disease can occur. The application described is based on returning the body to homeostasis (removing the problem and balancing the body) by providing lifeforce and not on dealing with the symptom (e.g., pain, vitamin deficiency). Imbalance results in various diseases and adverse health conditions (starting from aging to diabetes and cancers). This wonderful composition will interact with the body in a way that allows it to boost lifeforce and reach homeostasis no matter which direction it was.
    Type: Application
    Filed: February 4, 2010
    Publication date: August 4, 2011
    Inventors: Lorn Leitman, Gustavo Barni
  • Patent number: 7976882
    Abstract: The present invention relates to demucilaged flax sprouts derived from flaxseeds freed of their mucilage. The flax sprouts according to the invention are easily digestible and can be utilized in different fields, e.g. in food industry, therapy and hus-handry. The invention also relates to the production process and applications of the demucilaged flax sprouts. The present invention further relates to a process for recovering mucilaginous substance generated as a by-product in the production process as well as to various applications thereof.
    Type: Grant
    Filed: September 6, 2005
    Date of Patent: July 12, 2011
    Inventor: Ferenc Föglein
  • Publication number: 20110111073
    Abstract: Methods for separation and recovery of individual cyclic peptides from plant materials, said method comprising the steps of: (a) extracting an oil from a plant material; (b) separating the extracted oil into a non-polar fraction and a polar fraction; (c) separation and recovery of cyclic peptides from the non-polar fraction, and (d) separation and recovery of cyclic peptides from the polar fraction. The methods are suitable for separation and recovery of individual cyclolinopeptides from flax seed oil. Individual cyclolinopeptides are useful for modulation physiological disorders associated with apoptosis. Modified flaxseed oils may be produced by comingling flaxseed oils absent cyclolinopeptides, with at least one cyclolinopeptide separated and recovered with the methods disclosed herein.
    Type: Application
    Filed: December 22, 2008
    Publication date: May 12, 2011
    Applicant: University of Saskatchewan
    Inventors: Martin J. Reaney, Yunhua Jia, Jianheng Shen, Cynthia Schock, Nancy Tyler, Jim Elder, Sarabjeet Singh
  • Publication number: 20100329976
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 30, 2010
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • Publication number: 20100322853
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 23, 2010
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • Publication number: 20100322852
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 23, 2010
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • Publication number: 20100316744
    Abstract: The present invention relates to plant sprout-based stable oil-in-water emulsions wherein the monacyl- and diacylglycerol content is at least 20% by weight, the free fatty acid content is not more than 10% by weight and comprise an aqueous homogenate of sprouted oily seeds of which the own enzymes and emulsifying substances are capable to form the emulsion. Furthermore, the invention also relates to the preparation of said emulsions as well as to various applications thereof.
    Type: Application
    Filed: June 17, 2008
    Publication date: December 16, 2010
    Inventor: Ferenc Foglein
  • Patent number: 7816075
    Abstract: The use of screening assays based on the role of human stearoyl-CoA desaturase-1 (“hSCD1”) in human diseases, disorders or conditions relating to serum levels of triglyceride, VLDL, HDL, LDL, total cholesterol, or production of secretions from mucous membranes, monounsaturated fatty acids, wax esters, and the like, is disclosed. Also disclosed are conventions useful in the prevention and/or treatment of such diseases.
    Type: Grant
    Filed: July 11, 2005
    Date of Patent: October 19, 2010
    Assignees: Xenon Pharmaceuticals Inc., Wisconsin Alumni Research Foundation
    Inventors: Michael R. Hayden, Alison J. Brownlie, James M. Ntambi, Makoto Miyazaki, Mark P. Gray-Keller, Alan D. Attie
  • Publication number: 20100239696
    Abstract: This invention relates to methods and compositions for treating pathological lung conditions using whole-grain flaxseed or flaxseed lignans (isolated in form of the lignan precursor Secoisolariciresinol diglucoside (SDG) directly from whole-grain flaxseed or chemically synthesized directly into the mammalian, readily metabolizable forms, Enterodiol (ED) or Enterolactone (EL). Such pathological condition result from oxidative lung injury such as ischemia-reperfusion injury (related to lung transplantation), radiation fibrosis and cancer. Specifically, the invention is directed to the use of flaxseed lignans in the treatment of acute and chronic lung injury as well as cancer.
    Type: Application
    Filed: May 27, 2008
    Publication date: September 23, 2010
    Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventor: Melpo Christofidou-Solomidou
  • Patent number: 7776369
    Abstract: Process for obtaining lignan from plant material by extraction with an extraction solvent and separation of the liquid fraction from the plant material. The separated liquid fraction containing the lignan product is subjected to further processing to remove cyanogenic sugars and other impurities. The resulting lignan containing product may be formulated for the treatment of various conditions, such as cancer, diabetes, hypertension, lupus, and atherosclerosis.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: August 17, 2010
    Assignee: Archer-Daniels-Midland Company
    Inventors: Rishi Shukla, Ahmad K. Hilaly, Kevin M. Moore
  • Publication number: 20100196496
    Abstract: There are provided various compounds and compositions comprising polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds and compositions can be useful as cancer chemopreventive agents. They can also be useful for enhancing solubility of various active agents and enhancing their bioavailability.
    Type: Application
    Filed: August 6, 2009
    Publication date: August 5, 2010
    Inventor: Samuel FORTIN